Author

Shu-Ying Shen

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

HDAC1 maintains metabolic homeostasis in nucleus pulposus cells via post-translational modification interactions with YBX1

SU056@GelMA was developed to deliver the YBX1 inhibitor SU056, which improved ECM synthesis and reduced inflammation in rat and rabbit IVDD models and highlighted the potential of HDAC1 as a therapeutic target, suggesting future research on post-translational modifications in IVDD treatment.

Bo Zhou, Jie-Yun Xia, Zhao-Wei Zhang et al. · Experimental and Molecular M... · 0 citations

Review Jul 2026

RNA cytosine modifications regulates musculoskeletal disorders

This review systematically addresses the molecular basis and current knowledge on the mechanisms underlying RCMs in a variety of MSDs, along with translational strategies targeting these epitranscriptomic pathways.

Haitao Wang, Peirui Ke, Xing Zhao et al. · Molecular Biology Reports · 0 citations